SCHEMBL6543181

SCHEMBL6543181

O=C(O)c1cc2cc(OCc3c(Cl)cccc3Cl)ccc2n1S(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.59
BCL2 P10415 1/20 0.59
BID P55957 1/20 0.59
CCR2 P41597 2/20 0.55
PPARG P37231 1/20 0.47
SRD5A2 P31213 1/20 0.45
NR1H4 Q96RI1 1/20 0.43
NOD2 Q9HC29 2/20 0.42
NOD1 Q9Y239 2/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
ACLY P53396 1/20 0.41
MAPT P10636 1/20 0.39
HSD11B1 P28845 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7638737 0.90 BCL2 (0.59) MCL1BCL2BIDCCR2SRD5A2
SCHEMBL6542672 0.90 BCL2 (0.59) MCL1BCL2BIDCCR2PPARG
SCHEMBL7641620 0.86 MCL1 (0.52) MCL1BCL2BIDCCR2PPARG
SCHEMBL7638741 0.83 BCL2 (0.49) MCL1BCL2BIDCCR2SRD5A2
SCHEMBL7829429 0.82 CCR2 (0.66) MCL1BCL2BIDCCR2PPARG
SCHEMBL7644066 0.82 BCL2 (0.50) MCL1BCL2BIDCCR2PPARG
SCHEMBL6542674 0.82 BCL2 (0.48) MCL1BCL2BIDCCR2SRD5A2
SCHEMBL31159405 0.78 BCL2 (0.66) MCL1BCL2BIDCCR2PPARG
SCHEMBL7644069 0.75 BCL2 (0.40) MCL1BCL2BIDPPARGSRD5A2
SCHEMBL6598140 0.74 CCR2 (0.54) MCL1BCL2BIDCCR2SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187607-A4 INDOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2004-01-28 EP disclosed
US-6469046-B1 FABH INHIBITORS WHICH ARE USEFUL AS ANTIBIOTICS FOR THE TREATMENT OF GRAM POSITIVE AND GRAM NEGATIVE BACTERIAL INFECTIONS SMITHKLINE BEECHAM CORPORATION 2002-10-22 US disclosed
EP-1187607-A1 INDOLE COMPOUNDS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2000078309-A1 INDOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed